Compile Data Set for Download or QSAR
Report error Found 50 Enz. Inhib. hit(s) with all data for entry = 50009907
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089055(N*2*-(4-Ethanesulfonylmethyl-phenyl)-N*4*-phenyl-q...)
Affinity DataIC50: 0.600nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089048(N,N-Dimethyl-C-[4-(4-phenylamino-quinazolin-2-ylam...)
Affinity DataIC50: 0.900nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Rat)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CHEMBL17645 | Naphthalene-1-sulfonic a...)
Affinity DataIC50: 1.40nMAssay Description:Compound was tested for rat Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089069(N-[4-(4-Phenylamino-quinazolin-2-ylamino)-cyclohex...)
Affinity DataIC50: 2nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089060(Naphthalene-1-sulfonic acid [4-(4-amino-quinazolin...)
Affinity DataIC50: 2.70nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089036(Naphthalene-1-sulfonic acid {4-[2-(4-amino-quinazo...)
Affinity DataIC50: 2.90nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CHEMBL17645 | Naphthalene-1-sulfonic a...)
Affinity DataIC50: 2.90nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CHEMBL17645 | Naphthalene-1-sulfonic a...)
Affinity DataIC50: 2.90nMAssay Description:Compound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089070(4-Methyl-N-[4-(4-phenylamino-quinazolin-2-ylamino)...)
Affinity DataIC50: 4nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089065(N*2*-(4-Diethylamino-phenyl)-N*4*-phenyl-quinazoli...)
Affinity DataIC50: 4nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089063(Acetic acid 4-(4-phenylamino-quinazolin-2-ylamino)...)
Affinity DataIC50: 6nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089066(Naphthalene-1-sulfonic acid (4-{[(4-amino-quinazol...)
Affinity DataIC50: 16nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089050(N*2*-(4-Cyclohexyl-phenyl)-N*4*-phenyl-quinazoline...)
Affinity DataIC50: 20nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089058(Naphthalene-1-sulfonic acid [6-(4-amino-quinazolin...)
Affinity DataIC50: 28nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089044([4-(4-Phenylamino-quinazolin-2-ylamino)-benzyl]-ph...)
Affinity DataIC50: 33nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089054(N*2*-(4-Methoxy-phenyl)-N*4*-phenyl-quinazoline-2,...)
Affinity DataIC50: 33nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089033(Naphthalene-1-sulfonic acid {3-[(4-amino-quinazoli...)
Affinity DataIC50: 38nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089045(Naphthalene-1-sulfonic acid [7-(4-amino-quinazolin...)
Affinity DataIC50: 44nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089037(Naphthalene-1-sulfonic acid [8-(4-amino-quinazolin...)
Affinity DataIC50: 46nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089046(Naphthalene-2-sulfonic acid (4-{[(naphthalen-2-ylm...)
Affinity DataIC50: 47nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089047(N*2*-Cyclohexyl-N*4*-phenyl-quinazoline-2,4-diamin...)
Affinity DataIC50: 50nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089043(N*2*-{2-[1-(Naphthalene-1-sulfonyl)-piperidin-4-yl...)
Affinity DataIC50: 51nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089032(N-{4-[4-(4-Chloro-phenylamino)-quinazolin-2-ylamin...)
Affinity DataIC50: 58nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089040(N*2*,N*4*-Diphenyl-quinazoline-2,4-diamine | CHEMB...)
Affinity DataIC50: 80nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089067(N*2*-(4-Chloro-phenyl)-N*4*-phenyl-quinazoline-2,4...)
Affinity DataIC50: 100nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089051(Naphthalene-1-sulfonic acid {4-[(4-amino-quinazoli...)
Affinity DataIC50: 110nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089062(1'-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-4-cyclo...)
Affinity DataIC50: 160nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089057(N*4*-Phenyl-N*2*-p-tolyl-quinazoline-2,4-diamine |...)
Affinity DataIC50: 200nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089061(N*2*-(3-Dibutylamino-propyl)-N*4*-(3-trifluorometh...)
Affinity DataIC50: 210nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089031(N-{4-[4-(4-Chloro-phenylamino)-quinazolin-2-ylamin...)
Affinity DataIC50: 250nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089034(N*2*-(3,4-Dichloro-phenyl)-N*4*-phenyl-quinazoline...)
Affinity DataIC50: 270nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089053(Naphthalene-1-sulfonic acid 4-[(4-amino-quinazolin...)
Affinity DataIC50: 290nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089056(N-{4-[4-(4-Chloro-phenylamino)-quinazolin-2-ylamin...)
Affinity DataIC50: 310nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089059(Naphthalene-1-sulfonic acid 3-[(4-amino-quinazolin...)
Affinity DataIC50: 380nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089042(N-{4-[4-(4-Chloro-phenylamino)-quinazolin-2-ylamin...)
Affinity DataIC50: 390nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089052(Benzoic acid 4-(4-phenylamino-quinazolin-2-ylamino...)
Affinity DataIC50: 400nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089049(N*4*-(4-Chloro-phenyl)-N*2*-(4-methylaminomethyl-c...)
Affinity DataIC50: 510nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089064(Naphthalene-1-sulfonic acid (4-{[(4-amino-quinazol...)
Affinity DataIC50: 710nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089041([1-(Naphthalene-1-sulfonyl)-piperidin-4-ylmethyl]-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089061(N*2*-(3-Dibutylamino-propyl)-N*4*-(3-trifluorometh...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089035(2-[1-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-piper...)
Affinity DataIC50: 1.40E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 2(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CHEMBL17645 | Naphthalene-1-sulfonic a...)
Affinity DataIC50: 1.89E+3nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089039(N*2*-(4-Amino-butyl)-6-phenyl-quinazoline-2,4-diam...)
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 5(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089068(Naphthalene-1-sulfonic acid [(1R,2S)-2-(4-amino-qu...)
Affinity DataIC50: 4.90E+3nMAssay Description:Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 4(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CHEMBL17645 | Naphthalene-1-sulfonic a...)
Affinity DataIC50: 5.74E+3nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 4More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089039(N*2*-(4-Amino-butyl)-6-phenyl-quinazoline-2,4-diam...)
Affinity DataIC50: 8.00E+3nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089038(CGP 71683 | CHEMBL17645 | Naphthalene-1-sulfonic a...)
Affinity DataIC50: 8.37E+3nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089062(1'-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-4-cyclo...)
Affinity DataIC50: 8.90E+3nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089046(Naphthalene-2-sulfonic acid (4-{[(naphthalen-2-ylm...)
Affinity DataIC50: 1.00E+4nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeuropeptide Y receptor type 1(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089035(2-[1-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-piper...)
Affinity DataIC50: 6.00E+4nMAssay Description:Compound was tested for human Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed